NCT04507776View on ClinicalTrials.gov

Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel

CompletedOBSERVATIONAL
Enrollment

763

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

October 1, 2020

Study Completion Date

October 1, 2020

Conditions
Spondyloarthrosis
Interventions
DRUG

Etanercept

Patients with spondyloarthrosis as provided in real world practice

Trial Locations (1)

Unknown

Pfizer, Baghdad

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04507776 - Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel | Biotech Hunter | Biotech Hunter